HSP90B1 and bladder transitional cell carcinoma: The results indicated that HSP90B1 is highly expressed in multiple cancers, including bladder cancer (BLCA), prostate adenocarcinoma (PRAD), stomach adenocarcinoma (STAD), and kidney renal clear cell carcinoma (KIRC) (Fig. 1A).